- Advertisement -
Friday, September 25, 2020
33.5 C
Delhi
Home India DELHI Hizbul Mujahideen chief Syed Salahuddin attacked in Pakistan; ISI's role suspected

Hizbul Mujahideen chief Syed Salahuddin attacked in Pakistan; ISI’s role suspected

According to sources, the attack on the Hizbul chief was planned by Pakistan’s Inter-Services Intelligence (ISI). While further update on his health is awaited, speculations are rife that the attack on the Hizbul chief is linked to the recent tiff between ISI and Salauddin.

New Delhi: Hizbul Mujahideen chief Syed Salahuddin was left grievously injured after he was attacked by unknown assailants in Islamabad on May 25, as reliable sources from Pakistan.

According to sources, the attack on the Hizbul chief was planned by Pakistan’s Inter-Services Intelligence (ISI). While further update on his health is awaited, speculations are rife that the attack on the Hizbul chief is linked to the recent tiff between ISI and Salauddin.

Sources further revealed that the aim behind the attack was not to claim his life but send a message to the Hizbul chief. Meanwhile, Salahuddin was immediatly shifted to a safer place following the attack.

For the last few months, Salauddin, who also heads the United Jihad Council (UJC), a Pakistan-based conglomeration of various terror groups sponsored by ISI, was unhappy with the agency over the lack of support to Hizbul. Recent reports stated that Hizbul cadres were not provided adequate training, weapons and ammunition, thus allowing a major fallout between Salahuddin and the ISI. 

Moreover, after the elimination of Hizbul top commander Riyaz Naikoo in an encounter at south Kashmir by Indian Army, Salahuddin openly criticized the ISI during an interaction with the Hizbul cadres in PoJK.

Senior Hizbul sources in PoJK too believe that ISI may have planned to attack Salahuddin in a bid to send a strong signal to other outfit cadres to toe their line. 

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest news,

- Advertisement -

Stay Connected

8,000FansLike
2,458FollowersFollow
61,453SubscribersSubscribe

Must Read

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 
- Advertisement -

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

Related News

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

RUSSIA TO REGISTER SECOND CORONAVIRUS VACCINE BY OCTOBER 15

The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
- Advertisement -